115 related articles for article (PubMed ID: 24836277)
41. Epidemiology of hydatidiform mole and choriocarcinoma.
Bracken MB; Brinton LA; Hayashi K
Epidemiol Rev; 1984; 6():52-75. PubMed ID: 6386504
[TBL] [Abstract][Full Text] [Related]
42. Choriocarcinoma incidence in the United States.
Brinton LA; Bracken MB; Connelly RR
Am J Epidemiol; 1986 Jun; 123(6):1094-100. PubMed ID: 3706279
[TBL] [Abstract][Full Text] [Related]
43. Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study.
Ghabach B; Anderson WF; Curtis RE; Huycke MM; Lavigne JA; Dores GM
Breast Cancer Res; 2010; 12(4):R54. PubMed ID: 20653964
[TBL] [Abstract][Full Text] [Related]
44. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
Rihani R; Bazzeh F; Faqih N; Sultan I
Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
[TBL] [Abstract][Full Text] [Related]
45. Follicular thyroid cancer incidence patterns in the United States, 1980-2009.
Aschebrook-Kilfoy B; Grogan RH; Ward MH; Kaplan E; Devesa SS
Thyroid; 2013 Aug; 23(8):1015-21. PubMed ID: 23360496
[TBL] [Abstract][Full Text] [Related]
46. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
[TBL] [Abstract][Full Text] [Related]
47. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
48. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.
Henley SJ; King JB; German RR; Richardson LC; Plescia M;
MMWR Surveill Summ; 2010 Nov; 59(9):1-25. PubMed ID: 21102407
[TBL] [Abstract][Full Text] [Related]
49. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
50. Changing trends in gestational trophoblastic disease.
Smith HO; Wiggins C; Verschraegen CF; Cole LW; Greene HM; Muller CY; Qualls CR
J Reprod Med; 2006 Oct; 51(10):777-84. PubMed ID: 17086806
[TBL] [Abstract][Full Text] [Related]
51. Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus.
Sherman ME; Devesa SS
Cancer; 2003 Jul; 98(1):176-86. PubMed ID: 12833470
[TBL] [Abstract][Full Text] [Related]
52. Breast cancer in thyroid cancer survivors: An analysis of the Surveillance, Epidemiology, and End Results-9 database.
Kuo JH; Chabot JA; Lee JA
Surgery; 2016 Jan; 159(1):23-9. PubMed ID: 26522696
[TBL] [Abstract][Full Text] [Related]
53. Cancer of the corpus uteri in white and black women in Michigan, 1985-1994: an analysis of trends in incidence and mortality and their relation to histologic subtype and stage.
Madison T; Schottenfeld D; Baker V
Cancer; 1998 Oct; 83(8):1546-54. PubMed ID: 9781948
[TBL] [Abstract][Full Text] [Related]
54. Second primary anal and oropharyngeal cancers in cervical cancer survivors.
Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S
Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108
[TBL] [Abstract][Full Text] [Related]
55. Risk of Development of Second Primary Head and Neck Cancer following an Index Breast Cancer.
Yesensky J; Kyrillos A; Kuchta K; Yao K; Wang CH; Bhayani MK
Otolaryngol Head Neck Surg; 2018 Feb; 158(2):303-308. PubMed ID: 29039234
[TBL] [Abstract][Full Text] [Related]
56. Second primary lung cancer in United States Cancer Survivors, 1992-2008.
Donin NM; Kwan L; Lenis AT; Drakaki A; Chamie K
Cancer Causes Control; 2019 May; 30(5):465-475. PubMed ID: 30900065
[TBL] [Abstract][Full Text] [Related]
57. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.
Schonfeld SJ; Morton LM; Berrington de González A; Curtis RE; Kitahara CM
Cancer Epidemiol; 2020 Feb; 64():101664. PubMed ID: 31884334
[TBL] [Abstract][Full Text] [Related]
58. Childhood cancer among Alaska Natives.
Lanier AP; Holck P; Ehrsam Day G; Key C
Pediatrics; 2003 Nov; 112(5):e396. PubMed ID: 14595083
[TBL] [Abstract][Full Text] [Related]
59. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
60. Risk of myelodysplastic syndrome and acute myeloid leukemia post radiation treatment for breast cancer: a population-based study.
Kaplan H; Malmgren J; De Roos AJ
Breast Cancer Res Treat; 2013 Feb; 137(3):863-7. PubMed ID: 23274844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
